{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:05:27Z","timestamp":1774497927873,"version":"3.50.1"},"reference-count":10,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,2]]},"DOI":"10.1182\/blood-2017-01-761569","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T17:30:24Z","timestamp":1488475824000},"page":"1064-1065","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Immune reconstitution and remission in CML"],"prefix":"10.1182","volume":"129","author":[{"given":"David A.","family":"Scheinberg","sequence":"first","affiliation":[{"name":"SLOAN KETTERING INSTITUTE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"9","key":"2020051915542919100_B1","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2016-10-745992","article-title":"CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors","volume":"129","author":"Hughes","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2020051915542919100_B2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood-2009-10-250993","article-title":"Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia","volume":"116","author":"Maslak","year":"2010","journal-title":"Blood"},{"key":"2020051915542919100_B3","article-title":"PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies [published online ahead of print 18 October 2016]","author":"Qazilbash","journal-title":"Leukemia"},{"issue":"4","key":"2020051915542919100_B4","doi-asserted-by":"crossref","first-page":"e000068","DOI":"10.1136\/esmoopen-2016-000068","article-title":"Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study","volume":"1","author":"Gutzmer","year":"2016","journal-title":"ESMO Open"},{"issue":"2","key":"2020051915542919100_B5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.coi.2008.04.009","article-title":"WT1 peptide vaccine for the treatment of cancer","volume":"20","author":"Oka","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"23","key":"2020051915542919100_B6","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.2527.2527","article-title":"A therapeutic TCR mimic monoclonal antibody for intracellular PRAME protein in leukemias","volume":"126","author":"Chang","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2020051915542919100_B7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nbt.3349","article-title":"Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1","volume":"33","author":"Dao","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2020051915542919100_B8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/leu.2016.57","article-title":"Activity of 8F4, a T-cell receptor-like anti-PR1\/HLA-A2 antibody, against primary human AML in vivo","volume":"30","author":"Sergeeva","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"2020051915542919100_B9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.smim.2010.02.003","article-title":"Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation","volume":"22","author":"O\u2019Reilly","year":"2010","journal-title":"Semin Immunol"},{"key":"2020051915542919100_B10","article-title":"Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen [published online ahead of print 3 January 2017]","author":"Rafiq","journal-title":"Leukemia"}],"updated-by":[{"DOI":"10.1182\/blood-2018-10-879049","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/9\/1064\/1731613\/blood761569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/9\/1064\/1731613\/blood761569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T21:02:41Z","timestamp":1589922161000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/9\/1064\/36581\/Immune-reconstitution-and-remission-in-CML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-01-761569","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/blood-2018-10-879049","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}